These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 15161668)
1. A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts. Abi-Habib RJ; Liu S; Bugge TH; Leppla SH; Frankel AE Blood; 2004 Oct; 104(7):2143-8. PubMed ID: 15161668 [TBL] [Abstract][Full Text] [Related]
2. Enhanced ceramide generation and induction of apoptosis in human leukemia cells exposed to DT(388)-granulocyte-macrophage colony-stimulating factor (GM-CSF), a truncated diphtheria toxin fused to human GM-CSF. Senchenkov A; Han TY; Wang H; Frankel AE; Kottke TJ; Kaufmann SH; Cabot MC Blood; 2001 Sep; 98(6):1927-34. PubMed ID: 11535531 [TBL] [Abstract][Full Text] [Related]
3. A recombinant fusion toxin targeted to the granulocyte-macrophage colony-stimulating factor receptor. Bendel AE; Shao Y; Davies SM; Warman B; Yang CH; Waddick KG; Uckun FM; Perentesis JP Leuk Lymphoma; 1997 Apr; 25(3-4):257-70. PubMed ID: 9168436 [TBL] [Abstract][Full Text] [Related]
4. uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM-CSF but dependent on TIMP-1 in endothelial and glioblastoma cells. Raghu H; Nalla AK; Gondi CS; Gujrati M; Dinh DH; Rao JS Mol Oncol; 2012 Feb; 6(1):33-47. PubMed ID: 22177802 [TBL] [Abstract][Full Text] [Related]
5. Malignant progenitors from patients with acute myelogenous leukemia are sensitive to a diphtheria toxin-granulocyte-macrophage colony-stimulating factor fusion protein. Hogge DE; Willman CL; Kreitman RJ; Berger M; Hall PD; Kopecky KJ; McLain C; Tagge EP; Eaves CJ; Frankel AE Blood; 1998 Jul; 92(2):589-95. PubMed ID: 9657759 [TBL] [Abstract][Full Text] [Related]
6. DT388-GM-CSF, a novel fusion toxin consisting of a truncated diphtheria toxin fused to human granulocyte-macrophage colony-stimulating factor, prolongs host survival in a SCID mouse model of acute myeloid leukemia. Hall PD; Willingham MC; Kreitman RJ; Frankel AE Leukemia; 1999 Apr; 13(4):629-33. PubMed ID: 10214872 [TBL] [Abstract][Full Text] [Related]
7. Malignant progenitors from patients with CD87+ acute myelogenous leukemia are sensitive to a diphtheria toxin-urokinase fusion protein. Frankel AE; Beran M; Hogge DE; Powell BL; Thorburn A; Chen YQ; Vallera DA Exp Hematol; 2002 Nov; 30(11):1316-23. PubMed ID: 12423685 [TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia cells in G0 phase of the cell cycle that are unresponsive to conventional chemotherapy are sensitive to treatment with granulocyte-macrophage colony-stimulating factor/diphtheria toxin fusion proteins. Jedema I; Barge RM; Frankel AE; Willemze R; Falkenburg JH Exp Hematol; 2004 Feb; 32(2):188-94. PubMed ID: 15102480 [TBL] [Abstract][Full Text] [Related]
9. A urokinase-activated recombinant anthrax toxin is selectively cytotoxic to many human tumor cell types. Abi-Habib RJ; Singh R; Liu S; Bugge TH; Leppla SH; Frankel AE Mol Cancer Ther; 2006 Oct; 5(10):2556-62. PubMed ID: 17041100 [TBL] [Abstract][Full Text] [Related]
10. The diphtheria toxin/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells. Ramage JG; Vallera DA; Black JH; Aplan PD; Kees UR; Frankel AE Leuk Res; 2003 Jan; 27(1):79-84. PubMed ID: 12479856 [TBL] [Abstract][Full Text] [Related]
11. A murine cytokine fusion toxin specifically targeting the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells. Chan CH; Blazar BR; Eide CR; Kreitman RJ; Vallera DA Blood; 1995 Oct; 86(7):2732-40. PubMed ID: 7670112 [TBL] [Abstract][Full Text] [Related]
12. Targeting urokinase-type plasminogen activator receptor on human glioblastoma tumors with diphtheria toxin fusion protein DTAT. Vallera DA; Li C; Jin N; Panoskaltsis-Mortari A; Hall WA J Natl Cancer Inst; 2002 Apr; 94(8):597-606. PubMed ID: 11959893 [TBL] [Abstract][Full Text] [Related]
13. Modulation of the apoptotic response of human myeloid leukemia cells to a diphtheria toxin granulocyte-macrophage colony-stimulating factor fusion protein. Frankel AE; Hall PD; Burbage C; Vesely J; Willingham M; Bhalla K; Kreitman RJ Blood; 1997 Nov; 90(9):3654-61. PubMed ID: 9345050 [TBL] [Abstract][Full Text] [Related]
14. Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells. Feuring-Buske M; Frankel A; Gerhard B; Hogge D Exp Hematol; 2000 Dec; 28(12):1390-400. PubMed ID: 11146161 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of a recombinant diphtheria toxin-granulocyte colony-stimulating factor fusion protein on human leukemic blast cells. Chadwick DE; Williams DP; Niho Y; Murphy JR; Minden MD Leuk Lymphoma; 1993 Oct; 11(3-4):249-62. PubMed ID: 7505148 [TBL] [Abstract][Full Text] [Related]
16. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor and Ara-C exert synergistic toxicity against human AML HL-60 cells. Kim CN; Bhalla K; Kreitman RJ; Willingham MC; Hall P; Tagge EP; Jia T; Frankel AE Leuk Res; 1999 Jun; 23(6):527-38. PubMed ID: 10374846 [TBL] [Abstract][Full Text] [Related]
17. Recombinant toxins containing human granulocyte-macrophage colony-stimulating factor and either pseudomonas exotoxin or diphtheria toxin kill gastrointestinal cancer and leukemia cells. Kreitman RJ; Pastan I Blood; 1997 Jul; 90(1):252-9. PubMed ID: 9207460 [TBL] [Abstract][Full Text] [Related]
18. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645 [TBL] [Abstract][Full Text] [Related]
19. Regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in a GM-CSF-dependent human myeloid leukemia cell line (AML-193) by interleukin-6. Li Y; Valeriote F; Chen B Exp Hematol; 1996 Feb; 24(2):94-100. PubMed ID: 8641372 [TBL] [Abstract][Full Text] [Related]
20. A urokinase-type plasminogen activator-inhibiting cyclic peptide with an unusual P2 residue and an extended protease binding surface demonstrates new modalities for enzyme inhibition. Hansen M; Wind T; Blouse GE; Christensen A; Petersen HH; Kjelgaard S; Mathiasen L; Holtet TL; Andreasen PA J Biol Chem; 2005 Nov; 280(46):38424-37. PubMed ID: 16141208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]